CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 8, 2020Compositions Comprising Amlodipine And Bisoprolol1
May 1, 2019Compositions Comrrising Amlodipine And Bisoprolol1